223 related articles for article (PubMed ID: 26567993)
1. Serum Oxidative/anti-oxidative Stress Balance Is Dysregulated in Potentially Pulmonary Hypertensive Patients with Liver Cirrhosis: A Case Control Study.
Terao M; Takaki A; Maruyama T; Oe H; Yasunaka T; Tamaki N; Nakamura K; Tomofuji T; Yagi T; Sadamori H; Umeda Y; Shinoura S; Yoshida R; Nouso K; Ekuni D; Koike K; Ikeda F; Shiraha H; Morita M; Ito H; Fujiwara T; Yamamoto K
Intern Med; 2015; 54(22):2815-26. PubMed ID: 26567993
[TBL] [Abstract][Full Text] [Related]
2. A subclinical high tricuspid regurgitation pressure gradient independent of the mean pulmonary artery pressure is a risk factor for the survival after living donor liver transplantation.
Saragai Y; Takaki A; Umeda Y; Matsusaki T; Yasunaka T; Oyama A; Kaku R; Nakamura K; Yoshida R; Nobuoka D; Kuise T; Takagi K; Adachi T; Wada N; Takeuchi Y; Koike K; Ikeda F; Onishi H; Shiraha H; Nakamura S; Morimatsu H; Ito H; Fujiwara T; Yagi T; Okada H
BMC Gastroenterol; 2018 May; 18(1):62. PubMed ID: 29764373
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary vascular abnormalities in cirrhosis.
Herve P; Le Pavec J; Sztrymf B; Decante B; Savale L; Sitbon O
Best Pract Res Clin Gastroenterol; 2007; 21(1):141-59. PubMed ID: 17223502
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary vascular disease and exercise hemodynamics in chronic liver disease.
Douschan P; Kovacs G; Sassmann T; Stadlbauer V; Avian A; Foris V; Tatscher E; Durchschein F; Rainer F; Spindelboeck W; Wagner M; Kniepeiss D; Zollner G; Bachmaier G; Fickert P; Olschewski H; Stauber RE
Respir Med; 2022 Oct; 202():106987. PubMed ID: 36115317
[TBL] [Abstract][Full Text] [Related]
5. Liver transplantation in high-risk patients: hepatopulmonary syndrome and portopulmonary hypertension.
Martínez-Palli G; Taurà P; Balust J; Beltrán J; Zavala E; Garcia-Valdecasas JC
Transplant Proc; 2005 Nov; 37(9):3861-4. PubMed ID: 16386564
[TBL] [Abstract][Full Text] [Related]
6. Reduced circulating BMP10 and BMP9 and elevated endoglin are associated with disease severity, decompensation and pulmonary vascular syndromes in patients with cirrhosis.
Owen NE; Alexander GJ; Sen S; Bunclark K; Polwarth G; Pepke-Zaba J; Davenport AP; Morrell NW; Upton PD
EBioMedicine; 2020 Jun; 56():102794. PubMed ID: 32454407
[TBL] [Abstract][Full Text] [Related]
7. Onset ages of hepatopulmonary syndrome and pulmonary hypertension in patients with biliary atresia.
Ueno T; Saka R; Takama Y; Yamanaka H; Tazuke Y; Bessho K; Okuyama H
Pediatr Surg Int; 2017 Oct; 33(10):1053-1057. PubMed ID: 28871319
[TBL] [Abstract][Full Text] [Related]
8. Hepatopulmonary Syndrome and Portopulmonary Hypertension: Implications for Liver Transplantation.
Iqbal S; Smith KA; Khungar V
Clin Chest Med; 2017 Dec; 38(4):785-795. PubMed ID: 29128026
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in the approach to hepatopulmonary syndrome and portopulmonary hypertension.
Raevens S; Geerts A; Devisscher L; Van Vlierberghe H; Van Steenkiste C; Colle I
Acta Gastroenterol Belg; 2021; 84(1):95-99. PubMed ID: 33639700
[TBL] [Abstract][Full Text] [Related]
10. [Pulmonary complication of liver disease].
Dollinger MM
Praxis (Bern 1994); 2006 Oct; 95(40):1539-42. PubMed ID: 17048411
[TBL] [Abstract][Full Text] [Related]
11. Evidence for an Association Between Intrahepatic Vascular Changes and the Development of Hepatopulmonary Syndrome.
Lejealle C; Paradis V; Bruno O; de Raucourt E; Francoz C; Soubrane O; Lebrec D; Bedossa P; Valla D; Mal H; Vilgrain V; Durand F; Rautou PE
Chest; 2019 Jan; 155(1):123-136. PubMed ID: 30292761
[TBL] [Abstract][Full Text] [Related]
12. Intrapulmonary vascular dilatations are common in portopulmonary hypertension and may be associated with decreased survival.
Fussner LA; Iyer VN; Cartin-Ceba R; Lin G; Watt KD; Krowka MJ
Liver Transpl; 2015 Nov; 21(11):1355-64. PubMed ID: 26077312
[TBL] [Abstract][Full Text] [Related]
13. Coexisting hepatopulmonary syndrome and portopulmonary hypertension: implications for liver transplantation.
Pham DM; Subramanian R; Parekh S
J Clin Gastroenterol; 2010 Aug; 44(7):e136-40. PubMed ID: 20463591
[TBL] [Abstract][Full Text] [Related]
14. Liver in cardiopulmonary disease.
Polavarapu N; Tripathi D
Best Pract Res Clin Gastroenterol; 2013 Aug; 27(4):497-512. PubMed ID: 24090938
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic options in pulmonary hepatic vascular diseases.
Horvatits T; Fuhrmann V
Expert Rev Clin Pharmacol; 2014 Jan; 7(1):31-42. PubMed ID: 24308785
[TBL] [Abstract][Full Text] [Related]
16. Portopulmonary hypertension and hepatopulmonary syndrome: a clinician-oriented overview.
Porres-Aguilar M; Altamirano JT; Torre-Delgadillo A; Charlton MR; Duarte-Rojo A
Eur Respir Rev; 2012 Sep; 21(125):223-33. PubMed ID: 22941887
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary complications in chronic liver disease.
Machicao VI; Balakrishnan M; Fallon MB
Hepatology; 2014 Apr; 59(4):1627-37. PubMed ID: 24089295
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary Complications of Portal Hypertension.
Bommena S; Fallon MB
Clin Liver Dis; 2024 Aug; 28(3):467-482. PubMed ID: 38945638
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary complications of cirrhosis.
Kochar R; Nevah Rubin MI; Fallon MB
Curr Gastroenterol Rep; 2011 Feb; 13(1):34-9. PubMed ID: 21125431
[TBL] [Abstract][Full Text] [Related]
20. [Pulmonary complications in liver diseases].
Horvatits T; Drolz A; Rutter K; Kluge S; Fuhrmann V
Med Klin Intensivmed Notfmed; 2014 May; 109(4):235-9. PubMed ID: 24763525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
